Logotype for Optomed

Optomed (OPTOMED) investor relations material

Optomed Q3 2025 earnings summary

Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.
Logotype for Optomed
Q3 2025 earnings summary6 Nov, 2025

Executive summary

  • Achieved 47.0% currency-adjusted revenue growth in Q3 2025, with Devices segment as the main growth driver, especially in the US market.

  • Devices segment revenue surged 183.6% in Q3, while Software segment revenue declined 8.0% due to timing and price erosion in non-healthcare consulting.

  • Aurora AEYE and strategic collaborations, including a global pharma partnership and China joint venture, progressed as planned.

  • EBITDA improved to -€536K from -€814K, reflecting better scale and cost management.

  • Cash and cash equivalents at period end were €5.3M, with a strong equity ratio in the mid-70s percentage.

Financial highlights

  • Q3 2025 revenue rose to €4.42M, up 42.1% year-over-year; Devices: €2.31M (+183.6%), Software: €2.11M (-8.0%).

  • Gross margin improved to 61.8% from 54.4% year-over-year; EBITDA margin improved to -12.1% from -26.2%.

  • Net loss for Q3: €-1.53M (vs. €-1.6M Q3 2024); EPS: €-0.08 (vs. €-0.09).

  • Cash flow from operating activities improved to -€1.04M from -€1.43M.

  • Net debt at period end: €-3.68M (improved from €-8.3M y/y).

Outlook and guidance

  • Expects full-year 2025 revenue to grow strongly versus 2024, driven by AI-powered screening adoption, new partnerships, and a robust order book.

  • US FDA clearance and new collaborations are key growth drivers; software segment faces a challenging market.

  • Cost reduction and streamlining program to be implemented in 2026 to further improve profitability.

  • Uncertainties include timing of large deals, geopolitics, forex, and a one-off €1.5M order in Q4 2024.

Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.

Next Optomed earnings date

Logotype for Optomed
Q4 202510 Feb, 2026
Your earnings 
season toolkit.
Download
Free on both iOS & Android.

Next Optomed earnings date

Logotype for Optomed
Q4 202510 Feb, 2026

The essential earnings season companion

The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.

Live calls and transcripts

Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.

Find what you need faster

Search for any keyword across all transcripts simultaneously.

Easily store key findings

Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Your watchlist. Your dashboard.

Follow the companies that matter to you. Get a personalized feed with real-time updates.

Be the first to know

Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.

Consensus estimates

Access analyst consensus estimates, valuation multiples, and revenue segments splits.

All IR material in one place

The easiest way to stay updated during earnings season.

Global coverage

All events from public companies. Live and recorded.

Just click and listen

No webcast links. No manual registrations.

Research anytime, anywhere

Built for professionals. Loved by everyone. Try our free mobile app.

excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com

Frequently asked questions

Optomed Oyj, a Finnish medical technology company, manufactures and sells handheld fundus cameras and screening software for detecting ocular fundus pathologies. The company offers the Orbis portable camera and portable screening software, which allows ophthalmologists to screen patients’ eyes to detect ocular fundus diseases; and the Visio retina screener, a handheld retinal camera with screening software, designed to screen patients at-risk of cardiovascular diseases. Optomed Oyj is based in Oulu, Finland.

Quartr provides global coverage of all investor relation material from public companies.

  • Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.

  • Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.

  • Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.

Yes, the Quartr mobile app is free on both iOS and Android.

Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.

Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.

Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.

Explore our global coverage